Bluebird bio receives higher upfront offer from PE firms Carlyle, SK Capital

Reuters

Wed, May 14, 2025, 5:51 AM

(Reuters) -Bluebird bio and Carlyle Group and SK Capital Partners said connected Wednesday that the backstage equity firms person offered $5 per stock upfront to takeover the cistron therapy maker.

Shareholders whitethorn elite to person either the caller connection oregon the erstwhile connection of $3 per share, with an further $6.84 contingent upon bluebird achieving definite income milestones.

(Reporting by Puyaan Singh successful Bengaluru' Editing by Anil D'Silva)